Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alizyme plc
Alizyme reports positive preliminary results of phase IIa trial of ATL-104 for mucositis
April 8th, 2006
Alizyme plc (AZM) announced successful preliminary results of its phase IIa clinical trial to evaluate ATL-104 for the treatment of mucositis, which demonstrated positive responses in patients. The multicenter pilot clinical trial used a randomized, double-blind design, comparing three doses of ATL-104 with placebo on the incidence and severity of mucositis in patients undergoing chemotherapy, prior to autologous peripheral blood stem cell transplantation for the treatment of myeloma and/or lymphoma. The trial enrolled 64 patients and was conducted at 8 centers in the United Kingdom. This trial was a pilot proof of concept study, and was not designed...
Source: Law & Health Weekly (2006-04-08)
|
